Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

laboratories

Quest Ready to Move on Unilab, Announces Its 2002 Earnings

PERSISTENCE IS ABOUT TO PAY OFF for Quest Diagnostics Incorporated. After ten months of effort, it expects to finalize its acquisition of Unilab Corporation within weeks. But the Unilab acquisition soon to close looks different than the acquisition that was original…

Read More



“February 10, 2003 Intelligence: Late Breaking Lab News”

IMPATH, Inc. has replaced its long-time Chairman and CEO in the wake of a scandal involving expense accounts. The resignation of Anu D. Saad, Ph.D., was accepted and became effective today. In her place, IMPATH named Carter H. Eckert, an existing Director, as the new Chairman and CEO…

Read More



Why There’s “Bad Blood” Against National Labs

I AM FREQUENTLY ASKED BY WALL STREET TYPES why there seems to be latent, even deep-seated animosity between a large number of local laboratories and both of the two blood brothers. They wonder why, for example, hospital laboratories aren’t more interested in doing collaborative ventures with either…

Read More



New Trends in 2003 Affect Clinical Lab Services

CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with b…

Read More



New Market Channel For Esoteric Testing

CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab direc…

Read More



“January 20, 2003 Intelligence: Late Breaking Lab News”

December proved to be an eventful month for many companies in the lab industry. Here’s some key items of interest, many to be followed in more detail in coming issues of THE DARK REPORT: •AmeriPath, Inc. is to be sold to Welsh, Carson, Anderson & Stowe, a privat…

Read More



Grasping the Impact of the Genetic Revolution

IT’S BEEN SEVEN MONTHS since healthcare futurist Rick J. Carlson shared his insights about the impending genomic/proteomic revolution at the Executive War College in NewnOrleans last May. A key theme of his message was that diagnostic services would be squarely in the middle of the coming genetics…

Read More



Laboratories Sit Squarely Between New Genetics and Today’s Medicine

“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson. CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary…

Read More



Patient Safety is Related to “Quality Management”

REMEMBER BACK IN 1997 WHEN LABORATORY COMPLIANCE PROGRAMS were mandated by Medicare officials? That was a big thing in the laboratory industry. Every laboratory organization in the United States scrambled to assess their laboratory’s operating practices, develop policies, and create a compliance ma…

Read More



Several Major Surprises Mark Events of 2002

CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management syst…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;